On the 'classification' of neurodegenerative disorders

discrete entities, overlap or continuum?

Richard A. Armstrong

Research output: Contribution to journalArticle

Abstract

The traditional method of classifying neurodegenerative diseases is based on the original clinico-pathological concept supported by 'consensus' criteria and data from molecular pathological studies. This review discusses first, current problems in classification resulting from the coexistence of different classificatory schemes, the presence of disease heterogeneity and multiple pathologies, the use of 'signature' brain lesions in diagnosis, and the existence of pathological processes common to different diseases. Second, three models of neurodegenerative disease are proposed: (1) that distinct diseases exist ('discrete' model), (2) that relatively distinct diseases exist but exhibit overlapping features ('overlap' model), and (3) that distinct diseases do not exist and neurodegenerative disease is a 'continuum' in which there is continuous variation in clinical/pathological features from one case to another ('continuum' model). Third, to distinguish between models, the distribution of the most important molecular 'signature' lesions across the different diseases is reviewed. Such lesions often have poor 'fidelity', i.e., they are not unique to individual disorders but are distributed across many diseases consistent with the overlap or continuum models. Fourth, the question of whether the current classificatory system should be rejected is considered and three alternatives are proposed, viz., objective classification, classification for convenience (a 'dissection'), or analysis as a continuum.
Original languageEnglish
Pages (from-to)201-218
Number of pages18
JournalFolia Neuropathologica
Volume50
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint

Neurodegenerative Diseases
Pathologic Processes
Dissection
Pathology
Brain

Bibliographical note

Creative Commons Attribution Non-Commercial Share Alike International 4.0

Keywords

  • neurodegenerative disease
  • discrete entities
  • disease overlap
  • continuum
  • fidelity
  • ‘signature’ brain lesions

Cite this

@article{3af5c803c5384969a2fd115e40312f43,
title = "On the 'classification' of neurodegenerative disorders: discrete entities, overlap or continuum?",
abstract = "The traditional method of classifying neurodegenerative diseases is based on the original clinico-pathological concept supported by 'consensus' criteria and data from molecular pathological studies. This review discusses first, current problems in classification resulting from the coexistence of different classificatory schemes, the presence of disease heterogeneity and multiple pathologies, the use of 'signature' brain lesions in diagnosis, and the existence of pathological processes common to different diseases. Second, three models of neurodegenerative disease are proposed: (1) that distinct diseases exist ('discrete' model), (2) that relatively distinct diseases exist but exhibit overlapping features ('overlap' model), and (3) that distinct diseases do not exist and neurodegenerative disease is a 'continuum' in which there is continuous variation in clinical/pathological features from one case to another ('continuum' model). Third, to distinguish between models, the distribution of the most important molecular 'signature' lesions across the different diseases is reviewed. Such lesions often have poor 'fidelity', i.e., they are not unique to individual disorders but are distributed across many diseases consistent with the overlap or continuum models. Fourth, the question of whether the current classificatory system should be rejected is considered and three alternatives are proposed, viz., objective classification, classification for convenience (a 'dissection'), or analysis as a continuum.",
keywords = "neurodegenerative disease, discrete entities, disease overlap, continuum, fidelity, ‘signature’ brain lesions",
author = "Armstrong, {Richard A.}",
note = "Creative Commons Attribution Non-Commercial Share Alike International 4.0",
year = "2012",
doi = "10.5114/fn.2012.30521",
language = "English",
volume = "50",
pages = "201--218",
journal = "Folia Neuropathologica",
issn = "1641-4640",
publisher = "Polish Association of Neuropathologists",
number = "3",

}

On the 'classification' of neurodegenerative disorders : discrete entities, overlap or continuum? / Armstrong, Richard A.

In: Folia Neuropathologica, Vol. 50, No. 3, 2012, p. 201-218.

Research output: Contribution to journalArticle

TY - JOUR

T1 - On the 'classification' of neurodegenerative disorders

T2 - discrete entities, overlap or continuum?

AU - Armstrong, Richard A.

N1 - Creative Commons Attribution Non-Commercial Share Alike International 4.0

PY - 2012

Y1 - 2012

N2 - The traditional method of classifying neurodegenerative diseases is based on the original clinico-pathological concept supported by 'consensus' criteria and data from molecular pathological studies. This review discusses first, current problems in classification resulting from the coexistence of different classificatory schemes, the presence of disease heterogeneity and multiple pathologies, the use of 'signature' brain lesions in diagnosis, and the existence of pathological processes common to different diseases. Second, three models of neurodegenerative disease are proposed: (1) that distinct diseases exist ('discrete' model), (2) that relatively distinct diseases exist but exhibit overlapping features ('overlap' model), and (3) that distinct diseases do not exist and neurodegenerative disease is a 'continuum' in which there is continuous variation in clinical/pathological features from one case to another ('continuum' model). Third, to distinguish between models, the distribution of the most important molecular 'signature' lesions across the different diseases is reviewed. Such lesions often have poor 'fidelity', i.e., they are not unique to individual disorders but are distributed across many diseases consistent with the overlap or continuum models. Fourth, the question of whether the current classificatory system should be rejected is considered and three alternatives are proposed, viz., objective classification, classification for convenience (a 'dissection'), or analysis as a continuum.

AB - The traditional method of classifying neurodegenerative diseases is based on the original clinico-pathological concept supported by 'consensus' criteria and data from molecular pathological studies. This review discusses first, current problems in classification resulting from the coexistence of different classificatory schemes, the presence of disease heterogeneity and multiple pathologies, the use of 'signature' brain lesions in diagnosis, and the existence of pathological processes common to different diseases. Second, three models of neurodegenerative disease are proposed: (1) that distinct diseases exist ('discrete' model), (2) that relatively distinct diseases exist but exhibit overlapping features ('overlap' model), and (3) that distinct diseases do not exist and neurodegenerative disease is a 'continuum' in which there is continuous variation in clinical/pathological features from one case to another ('continuum' model). Third, to distinguish between models, the distribution of the most important molecular 'signature' lesions across the different diseases is reviewed. Such lesions often have poor 'fidelity', i.e., they are not unique to individual disorders but are distributed across many diseases consistent with the overlap or continuum models. Fourth, the question of whether the current classificatory system should be rejected is considered and three alternatives are proposed, viz., objective classification, classification for convenience (a 'dissection'), or analysis as a continuum.

KW - neurodegenerative disease

KW - discrete entities

KW - disease overlap

KW - continuum

KW - fidelity

KW - ‘signature’ brain lesions

UR - http://www.scopus.com/inward/record.url?scp=84867025008&partnerID=8YFLogxK

UR - http://www.termedia.pl/Review-paper-On-the-classification-of-neurodegenerative-disorders-discrete-entities-overlap-or-continuum-,20,19340,0,1.html

U2 - 10.5114/fn.2012.30521

DO - 10.5114/fn.2012.30521

M3 - Article

VL - 50

SP - 201

EP - 218

JO - Folia Neuropathologica

JF - Folia Neuropathologica

SN - 1641-4640

IS - 3

ER -